CVS Group (LON:CVSG – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Berenberg Bank in a research report issued to clients and investors on Wednesday, MarketBeat.com reports. They currently have a GBX 2,000 price objective on the stock. Berenberg Bank’s price objective indicates a potential upside of 47.06% from the stock’s current price.
Several other equities analysts have also issued reports on CVSG. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 1,500 target price on shares of CVS Group in a report on Friday, August 29th. Peel Hunt restated a “buy” rating and issued a GBX 1,600 target price on shares of CVS Group in a report on Tuesday, October 7th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of GBX 1,700.
Check Out Our Latest Stock Report on CVSG
CVS Group Price Performance
CVS Group (LON:CVSG – Get Free Report) last released its earnings results on Tuesday, October 7th. The company reported GBX 80.10 earnings per share (EPS) for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. On average, analysts expect that CVS Group will post 93.9393939 earnings per share for the current year.
About CVS Group
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Read More
- Five stocks we like better than CVS Group
- How is Compound Interest Calculated?
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- The Role Economic Reports Play in a Successful Investment Strategy
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.